The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia.
Ashton TM, Fokas E, Kunz-Schughart LA, Folkes LK, Anbalagan S, Huether M, Kelly CJ, Pirovano G, Buffa FM, Hammond EM, Stratford M, Muschel RJ, Higgins GS, McKenna WG.
Ashton TM, et al.
Nat Commun. 2016 Jul 25;7:12308. doi: 10.1038/ncomms12308.
Nat Commun. 2016.
PMID: 27453292
Free PMC article.